High‑calorie versus standard enteral feeding to support growth and brain development in infants after congenital heart surgery
Official title: Effectiveness of High-Energy Density Enteral Nutrition for Enhancing Physical Growth and Cognitive Brain Development in Infants With Congenital Heart Disease: A Randomized Controlled Study
Run by Children's Hospital of Fudan University · NCT07115108 · Data updated 2026-11-12
This trial tests whether higher‑calorie tube or bottle feeding helps infants with congenital heart disease grow better and support early brain development after open‑heart surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 0 Months to 6 Months |
| Sex | All |
| Enrollment | 160 (estimated) |
| Sponsor | Children's Hospital of Fudan University Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | October 13, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | May 13, 2026 |
| Trial ID | NCT07115108 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Infants 0–6 months with diagnosed congenital heart disease, identified nutritional risk by STRONGkids, receiving artificial or mixed feeding, and scheduled for open heart surgery whose guardians provide informed consent.
✕Probably not a fit
Infants with major noncardiac conditions that impair feeding or growth (for example congenital gastrointestinal malformations, significant genetic syndromes like trisomy 21 or 18, or severe immune dysfunction) are excluded and unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Infants aged 0–6 months who have nutritional risk and undergo open heart surgery will receive either a high‑energy density enteral nutrition regimen or a standard‑energy regimen during postoperative recovery. The study compares physical growth measures (such as weight and length) and cognitive brain development outcomes between the two feeding approaches and monitors safety events. Guardians must consent before enrollment and feeding will be provided while children are on artificial or mixed feeding. Investigators will track growth over the postoperative period and use standardized developmental screening tools to capture early neurodevelopmental differences.
Why it matters
Potential benefit: If successful, the higher‑calorie enteral feeding could improve postoperative weight gain and support early cognitive development, reducing malnutrition and its downstream risks.
How similar studies have gone: Previous nutrition studies in preterm and medically vulnerable infants have shown that higher‑energy formulas can improve weight gain, but evidence specifically showing cognitive benefit after congenital heart surgery is limited and this application is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with congenital heart disease through symptoms, physical signs, imaging, and ultrasound examinations. * Age 0-6 months * Children with nutritional risks (defined by STRONGkids: Nutritional risk screening tool for children ) * Artificial or mixed feeding * Open heart surgery under cardiopulmonary bypass * The guardians of the children voluntarily participate in this study and sign a written informed consent form before the surgery. Exclusion Criteria: * Diagnosed with major non cardiac diseases leading to nutritional intake disorders, such as congenital gastrointestinal malformations, preoperative diagnosis of gastroesophageal reflux, genetic diseases related to growth restriction, and various syndromes with chromosomal abnormalities (trisomy 21 syndrome, trisomy 18 syndrome) * Abnormal immune system function due to congenital or acquired factors, unable to effectively resist pathogens or eliminate abnormal cells, which can be divided into primary and secondary immunodeficiencies. * Any pre - operative history of neurological diseases (e.g., encephalitis, epilepsy). * Secondary or primary gastrointestinal infection symptoms such as abdominal distension and diarrhea after surgery. * Estimated stay time in the postoperative intensive care unit ≤ 2 days
Where it's running
-
Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Xu Yulu
- Email: xuyulu05@163.com
- Phone: 8602164931532
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Wireless NIRS Sensor Use in the NICU for Monitoring on Neonates
A wireless NIRS sensor is tested on infants in the NICU to see how well it stays on and how it notes brain signals when used alongside standard wired sensors.
-
Screening for lipid disorders in children and teens with chronic diseases to flag cardiovascular risk
This study tests a blood test and a questionnaire to screen children and teens with chronic conditions for lipid metabolism disorders and familial hyperlipidemia.
-
Prehabilitation before heart surgery for adults with congenital heart disease
This study is testing whether a tailored, supervised exercise program before heart surgery helps adults with congenital heart disease perform better and improve fitness.
-
Using enteral (tube) feeding as recommended for adults with cancer.
This project will see how well enteral (tube) feeding recommendations are followed by adults hospitalized for cancer who need enteral nutrition.
-
Accessible care model comparing nurse-led versus physician-led transition education for teens and young adults with congenital heart disease
This project will test whether an accessible care model and nurse-led versus physician-led transition education helps teens and young adults (ages 12–26) with congenital heart disease move successfully from pediatric to adult heart care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.